- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14:42 | Beneficient Adds $35 Million In Permanent Equity, Aiming For Nasdaq Compliance | ||
| 14:42 | Earnings Summary: Dynagas LNG Partners Q3 | ||
| 14:42 | Tesla Gains 55% In A Month With Strong China Role, Bullish Signals | ||
| 14:42 | Petrobras Powers Ahead: $111 Billion Investment Plan Targets Green Growth And Big Dividends | ||
| 14:42 | Disney Takes on Netflix With High-Impact Originals in Asia | ||
| 14:42 | How Is The Market Feeling About Goldman Sachs Gr? | ||
| 14:42 | (W) - Analyzing Wayfair's Short Interest | ||
| 14:42 | Looking Into Marriott Intl's Recent Short Interest | ||
| 14:30 | Microsoft's Brad Smith Urges Trump Government to Tackle Growing Cyber Threats | ||
| 14:30 | The Post That Just Saved Us Money On Nvidia | ||
| 14:18 | Ark Invest's Cathie Wood Says Team Trump Would Give 'Regulatory Clarity' For Bitcoin And Other Digital Assets: '...Which They May Put In The Treasury's Strategic Reserve' | ||
| 14:18 | What's Going On With EHang Stock Today? | ||
| 14:18 | Leading And Lagging Sectors For November 22, 2024 | ||
| 14:06 | In-Depth Examination Of 9 Analyst Recommendations For Zymeworks | ||
| 14:06 | 6 Analysts Have This To Say About Sonic Automotive | ||
| 14:06 | In-Depth Examination Of 8 Analyst Recommendations For Foot Locker | ||
| 14:06 | Analyst Ratings For Lululemon Athletica | ||
| 14:06 | Navigating 8 Analyst Ratings For DocuSign | ||
| 14:06 | Breaking Down Timken: 6 Analysts Share Their Views | ||
| 14:06 | Charles Schwab Prepares For Spot Cryptocurrency Trading Under New Leadership | ||
| 14:06 | Top 2 Financials Stocks That May Fall Off A Cliff This Quarter | ||
| 13:54 | Top Wall Street Forecasters Revamp Blue Bird Price Expectations Ahead Of Q4 Earnings | ||
| 13:54 | Wall Street's Most Accurate Analysts Give Their Take On 3 Industrials Stocks With Over 3% Dividend Yields | ||
| 13:54 | Bitcoin Nears $100,000, 'Momentum Could Continue Well Beyond The Milestone,' Experts Note | ||
| 13:42 | Y-mAbs' Omburtamab Failure: The Critical Turning Point And $19.65M Shareholder Settlement |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
